Mytrex Health Technologies, Inc. (TPEX:4431)

Revenue by Product

Financials in millions TWD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009
Pharmaceutical Distribution	1.59B
Pharmaceutical Distribution Growth	43.14%
Technological Materials	109.80M
Technological Materials Growth	-18.53%
Medical and Biotechnology	53.33M
Medical and Biotechnology Growth	29.37%
Other	2.98M
Other Growth	-31.32%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009
Asia	1.75B
Asia Growth	37.56%
Europe	10.89M
Europe Growth	-48.01%
Other Countries	392.00K
Other Countries Growth	-77.18%